Reynders McVeigh Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-2,555
Closed -$271K 224
2015
Q4
$271K Buy
2,555
+221
+9% +$22.8K 0.04% 172
2015
Q3
$217K Sell
2,334
-105
-4% -$10.9K 0.04% 186
2015
Q2
$254K Sell
2,439
-2,915
-54% -$303K 0.04% 180
2015
Q1
$580K Sell
5,354
-102,747
-95% -$10.6M 0.1% 114
2014
Q4
$10M Sell
108,101
-8,832
-8% -$780K 1.76% 22
2014
Q3
$10.2M Buy
116,933
+28,838
+33% +$2.61M 1.94% 19
2014
Q2
$7.75M Buy
88,095
+134
+0.2% +$11.6K 1.76% 20
2014
Q1
$7.42M Buy
87,961
+6,699
+8% +$534K 1.76% 18
2013
Q4
$6.38M Buy
81,262
+512
+0.6% +$43.7K 1.58% 23
2013
Q3
$6.88M Buy
80,750
+599
+0.7% +$50.4K 1.91% 16
2013
Q2
$6.89M Buy
+80,151
New +$6.65M 2.04% 13

Other funds holding LH

Reynders McVeigh Capital Management's LH Position: Q1 2016 in Review

Reynders McVeigh Capital Management sold out of Labcorp (LH) in Q1 2016, closing a stake of 2,555 shares — an estimated $271K sold.

Reynders McVeigh Capital Management first reported a position in LH in Q2 2013 and held it in 11 quarters. The position peaked at $10.2M in Q3 2014. 631 funds tracked by Wall St. Rank hold LH as of Q1 2016.

  • Reynders McVeigh Capital Management reported no remaining Labcorp position as of Q1 2016 after selling out during the quarter.
  • Reynders McVeigh Capital Management sold 2,555 Labcorp shares in Q1 2016, an estimated $271K.
  • Reynders McVeigh Capital Management first reported a position in Labcorp in Q2 2013 and held it in 11 quarters.
  • Reynders McVeigh Capital Management's Labcorp position peaked at $10.2M in Q3 2014.
  • 631 funds tracked by Wall St. Rank held Labcorp as of Q1 2016.

Based on Reynders McVeigh Capital Management's 13F filing for Q1 2016, filed 13 May 2016.